LETTER TO THE JOURNAL
Discovery of a novel viroid-like circular RNA in colorectal cancer
Meini Wu, Wenliang Li, Ningzhu Hu, Changning Liu, Jianfang Li, Yanhan Li, Ning Xu, Jiandong Shi, Jing Sun, Jing Li, Yunzhang Hu
Cancer Communications 2024 44: [ PDF Full-text ] [ HTML Full-text ] [ PubMed] Epub: 11/9/2024 doi:10.1002/cac2.12626
RESEARCH HIGHLIGHT
FOXO1 or not FOXO1: that is the question
Maude Marchais, Marianne Mangeney
Cancer Communications 2024 44: [ PDF Full-text ] [ HTML Full-text ] [ PubMed] Epub: 11/7/2024 doi:10.1002/cac2.12624
REVIEW
Effect of neutrophils on tumor immunity and immunotherapy resistance with underlying mechanisms
Jiali Yao, Linlin Ji, Guang Wang, Jin Ding
Cancer Communications 2024 44: [ PDF Full-text ] [ HTML Full-text ] [ PubMed] Epub: 11/1/2024 doi:10.1002/cac2.12613
LETTER TO THE JOURNAL
Wnt/GSK-3β mediates posttranslational modifications of FLYWCH1 to regulate intestinal epithelial function and tumorigenesis in the colon
Sheema Almozyan, Roya Babaei-Jadidi, Abrar Aljohani, Sepideh Youssefi, William Dalleywater, Prerna Kadam, Bradley Spencer-Dene, Emad Rakha, Mohammad Ilyas, Abdolrahman Shams Nateri
Cancer Communications 2024 44: [ PDF Full-text ] [ HTML Full-text ] [ PubMed] Epub: 10/30/2024 doi:10.1002/cac2.12625
LETTER TO THE JOURNAL
Tumor derived cell-free nucleic acid upregulates programmed death-ligand 1 expression in neutrophil via intracellular Toll-like receptor signaling
Suguru Saito, Duo-Yao Cao, Tomohiro Shibata, Yan Liu, Aoi Otagiri-Hoshi, Xiaojiang Cui, Kenneth E. Bernstein
Cancer Communications 2024 44: [ PDF Full-text ] [ HTML Full-text ] [ PubMed] Epub: 10/30/2024 doi:10.1002/cac2.12615
LETTER TO THE JOURNAL
Engineering heavy chain antibody-drug conjugates against solid tumors for a one-shot kill
Xue Liu, Wenjing Ning, Lei Wang, Han Liu, Hongye Zeng, Xiaojing Qin, Yuanzhi Chen, Fentian Chen, Lin Xu, Yang Zhao, Xiaoqing Chen, Jixian Tang, Yunlong Ren, Xiaowen Yan, Wenxin Luo, Ningshao Xia
Cancer Communications 2024 44: [ PDF Full-text ] [ HTML Full-text ] [ PubMed] Epub: 10/25/2024 doi:10.1002/cac2.12616
ORIGINAL ARTICLE
HLX07 alone or combined with serplulimab, cisplatin and 5-fluorouracil for advanced esophageal squamous cell carcinoma: A phase 2 study
Yun Liu, Yanfeng Wang, Yanrong Zhu, Tao Wu, Zhenyang Liu, Jin Zhou, Yuan Yuan, Mudan Yang, Bo Liu, Zhenbo Tan, Wu Zhuang, Jiayan Chen, Ning Li, Ying Wang, Xuhui Hu, Lin Wang, Haoyu Yu, Qingyu Wang, Jun Zhu, Jing Huang
Cancer Communications 2024 44: [ PDF Full-text ] [ HTML Full-text ] [ PubMed] Epub: 10/24/2024 doi:10.1002/cac2.12621
LETTER TO THE JOURNAL
Acquired RD3 loss regulates immune surveillance in high-risk and therapy defying progressive neuroblastoma
Poorvi Subramanian, Sreenidhi Mohanvelu, Dinesh Babu Somasundaram, Sheeja Aravindan, Natarajan Aravindan
Cancer Communications 2024 44: [ PDF Full-text ] [ HTML Full-text ] [ PubMed] Epub: 10/24/2024 doi:10.1002/cac2.12620
LETTER TO THE JOURNAL
IL2-mediated modulation of small extracellular vesicles secretion and PD-L1 expression: a novel perspective for neutralizing immune suppression within cancer cells
Soojeong Noh, Suyeon Ryu, Dokyung Jung, Sanghee Shin, Inseong Jung, Sung-Min Kang, Christine Seulki Kim, Sung-Jin Choi, Hanchae Cho, Melanie Schw?mmle, Youngtae Jeong, Felicitas Bucher, Il-Kyu Choi, Shin Yup Lee, Sin-Hyeog Im, Kyungmoo Yea, Moon-Chang Bae
Cancer Communications 2024 44: [ PDF Full-text ] [ HTML Full-text ] [ PubMed] Epub: 10/23/2024 doi:10.1002/cac2.12623
LETTER TO THE JOURNAL
The long-term spatiotemporal trends in lung cancer burden and its risk factors at global, regional, and national levels, 1992-2021: The Global Burden of Disease Study 2021
Zegui Tu, Shuangsi Liao, Caini Chen, Caili Li, Qipeng Hu, Chengzhi Cai, Yang Yu, Jieyan Luo, Meijuan Huang
Cancer Communications 2024 44: [ PDF Full-text ] [ HTML Full-text ] [ PubMed] Epub: 10/18/2024 doi:10.1002/cac2.12622
